Volumetric analysis of the periodontal microstructure under antiresorptive therapy: an experimental study in rabbits.

Szczegóły
Abstrakt

Tytuł:: Volumetric analysis of the periodontal microstructure under antiresorptive therapy: an experimental study in rabbits.
Autorzy:: Becker K; Department for Orthodontics, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Kerberger R; Department for Orthodontics, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Brunello G; Department of Oral Surgery, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.; Department of Neuroscience, Dental School, University of Padova, Padova, Italy.
Rockhoff J; Department for Orthodontics, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Rauch N; Department of Oral Surgery, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Schwarz F; Department of Oral Surgery and Implantology, Goethe University, Carolinum, Frankfurt, Germany. .
Źródło:: Clinical oral investigations [Clin Oral Investig] 2022 Aug; Vol. 26 (8), pp. 5359-5368. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: Berlin : Springer-Verlag
Original Publication: Berlin : Springer, c1997-
MeSH Terms:: Diphosphonates*/pharmacology
Osteonecrosis*
Animals ; Rabbits ; Bone Density ; Maxilla ; Molar ; X-Ray Microtomography
References:: Barry E, Taylor T, Patel J, Hamid U, Bryant C (2021) The incidence of medication-related osteonecrosis of the jaw following tooth extraction in patients prescribed oral bisphosphonates. Br Dent J. https://doi.org/10.1038/s41415-021-3620-9. (PMID: 10.1038/s41415-021-3620-934815482)
Wick A, Bankosegger P, Otto S, Hohlweg-Majert B, Steiner T, Probst F, Ristow O, Pautke C (2021) Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab. Clin Oral Investig. https://doi.org/10.1007/s00784-021-04261-4. (PMID: 10.1007/s00784-021-04261-4348129598898220)
Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Investig 22:597–615. https://doi.org/10.1007/s00784-017-2325-6. (PMID: 10.1007/s00784-017-2325-629332231)
Alsalih A, Dam A, Lindberg P, Truedsson A (2021) Medication-related osteonecrosis of the jaws initiated by zoledronic acid and potential pathophysiology. Dent J (Basel) 9:85. https://doi.org/10.3390/dj9080085. (PMID: 10.3390/dj9080085)
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O (2017) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10:Cd012432. https://doi.org/10.1002/14651858.CD012432.pub2. (PMID: 10.1002/14651858.CD012432.pub228983908)
Schliephake H (2000) (2022) The role of systemic diseases and local conditions as risk factors. Periodontol 88:36–51. https://doi.org/10.1111/prd.12409. (PMID: 10.1111/prd.12409)
Lambrinoudaki I, Vlachou S, Galapi F, Papadimitriou D, Papadias K (2008) Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging 3:445–451. https://doi.org/10.2147/cia.s2046. (PMID: 10.2147/cia.s2046189829152682377)
Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922–932. https://doi.org/10.1111/jcpe.12455. (PMID: 10.1111/jcpe.1245526362756)
Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carriere P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol : Off J Eur Soc Med Oncol / ESMO 23:1341–1347. https://doi.org/10.1093/annonc/mdr435. (PMID: 10.1093/annonc/mdr435)
Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P (2009) Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast 18:213–217. https://doi.org/10.1016/j.breast.2009.07.001. (PMID: 10.1016/j.breast.2009.07.00119651512)
Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou A, Triaridis S (2008) Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol : Off J Am Soc Clin Oncol 26:4634–4638. https://doi.org/10.1200/JCO.2008.16.2768. (PMID: 10.1200/JCO.2008.16.2768)
Aguirre JI, Castillo EJ, Kimmel DB (2021) Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone 153:116184. https://doi.org/10.1016/j.bone.2021.116184. (PMID: 10.1016/j.bone.2021.116184345208988743993)
Schwarz F, John G, Becker J, Grotz KA, Sader R, Mihatovic I (2020) Influence of ridge preservation procedures on extraction socket healing under antiresorptive therapy: an experimental study in rabbits. Clin Implant Dent Relat Res 22:477–485. https://doi.org/10.1111/cid.12916. (PMID: 10.1111/cid.1291632537909)
Kim T, Kim S, Song M, Lee C, Yagita H, Williams DW, Sung EC, Hong C, Shin KH, Kang MK, Park NH, Kim RH (2018) Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw-like lesion in mice. Am J Pathol 188:2318–2327. https://doi.org/10.1016/j.ajpath.2018.06.019. (PMID: 10.1016/j.ajpath.2018.06.019300596566169128)
Kosach GA, Petrosyan AL, Yaremenko AI, Kutukova SI, Zubareva AA, Chefu SG, Vlasov TD (2021) Influence of the cumulative effect of zoledronic acid on periodontal microcirculation in rats. Oral Maxillofac Surg 25:487–494. https://doi.org/10.1007/s10006-021-00950-2. (PMID: 10.1007/s10006-021-00950-233586116)
Yu B, Wang CY (2022) Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000. https://doi.org/10.1111/prd.12422. (PMID: 10.1111/prd.12422352449459067601)
Moreno-Rabie C, Gaeta-Araujo H, Oliveira-Santos C, Politis C, Jacobs R (2020) Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review. Clin Oral Investig 24:2973–2989. https://doi.org/10.1007/s00784-020-03423-0. (PMID: 10.1007/s00784-020-03423-032627123)
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br J Pharmacol 177:3617–3624. https://doi.org/10.1111/bph.15193. (PMID: 10.1111/bph.15193326625197393194)
R Core Team (2021) R: a language and environment for statistical computing. Book title. R Foundation for Statistical Computing, Vienna, Austria.
Bates D, Mächler M, Bolker B and Walker S (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67 https://doi.org/10.18637/jss.v067.i01.
Dias DR, Leles CR, Batista AC, Lindh C, Ribeiro-Rotta RF (2015) Agreement between histomorphometry and microcomputed tomography to assess bone microarchitecture of dental implant sites. Clin Implant Dent Relat Res 17:732–741. https://doi.org/10.1111/cid.12176. (PMID: 10.1111/cid.1217624238279)
Parvini P, Schwarz F, Hufner MK, Rauch N, Nienkemper M, Becker K (2020) Microstructural volumetric analysis of vertical alveolar ridge augmentation using autogenous tooth roots. Clin Implant Dent Relat Res 22:647–653. https://doi.org/10.1111/cid.12947. (PMID: 10.1111/cid.1294732876385)
Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Min Res: Off J Am Soc Bone Min Res 25:1468–1486. https://doi.org/10.1002/jbmr.141. (PMID: 10.1002/jbmr.141)
Becker K, Drescher D, Honscheid R, Golubovic V, Mihatovic I, Schwarz F (2017) Biomechanical, micro-computed tomographic and immunohistochemical analysis of early osseous integration at titanium implants placed following lateral ridge augmentation using extracted tooth roots. Clin Oral Implant Res 28:334–340. https://doi.org/10.1111/clr.12803. (PMID: 10.1111/clr.12803)
Gonzalez-Garcia R, Monje F (2013) The reliability of cone-beam computed tomography to assess bone density at dental implant recipient sites: a histomorphometric analysis by micro-CT. Clin Oral Implant Res 24:871–879. https://doi.org/10.1111/j.1600-0501.2011.02390.x. (PMID: 10.1111/j.1600-0501.2011.02390.x)
de Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, Aghaloo TL, Tetradis S (2014) Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone 68:11–19. https://doi.org/10.1016/j.bone.2014.07.027. (PMID: 10.1016/j.bone.2014.07.027250932624476062)
Soundia A, Hadaya D, Esfandi N, de Molon RS, Bezouglaia O, Dry SM, Pirih FQ, Aghaloo T, Tetradis S (2016) Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Bone 90:133–141. https://doi.org/10.1016/j.bone.2016.06.011. (PMID: 10.1016/j.bone.2016.06.011273274105471352)
Vilarinho JLP, Ferrare N, Moreira AMR, Moura HF, Acevedo AC, Chaves SB, Melo NS, Leite AF, Macedo SB, de Souza MP, Guimaraes ATB, Figueiredo PT (2017) Early bony changes associated with bisphosphonate-related osteonecrosis of the jaws in rats: a longitudinal in vivo study. Arch Oral Biol 82:79–85. https://doi.org/10.1016/j.archoralbio.2017.06.002. (PMID: 10.1016/j.archoralbio.2017.06.00228622548)
Soares MQS, Van Dessel J, Jacobs R, da Silva Santos PS, Cestari TM, Garlet GP, Duarte MAH, Imada TSN, Lambrichts I, Rubira-Bullen IRF (2018) Zoledronic acid induces site-specific structural changes and decreases vascular area in the alveolar bone. J Oral Maxillofac Surg 76:1893–1901. https://doi.org/10.1016/j.joms.2018.03.007. (PMID: 10.1016/j.joms.2018.03.00729626448)
Kim I, Ki H, Lee W, Kim H, Park JB (2013) The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla. Int J Oral Maxillofac Implants 28:1194–1200. https://doi.org/10.11607/jomi.2685. (PMID: 10.11607/jomi.268524066308)
Kuroshima S, Sasaki M, Murata H, Sawase T (2019) Medication-related osteonecrosis of the jaw-like lesions in rodents: a comprehensive systematic review and meta-analysis. Gerodontology 36:313–324. https://doi.org/10.1111/ger.12416. (PMID: 10.1111/ger.1241631373407)
Imada M, Yagyuu T, Ueyama Y, Maeda M, Yamamoto K, Kurokawa S, Jo JI, Tabata Y, Tanaka Y, Kirita T (2019) Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: an experimental study in rats. PLoS ONE 14:e0211928. https://doi.org/10.1371/journal.pone.0211928. (PMID: 10.1371/journal.pone.0211928307355546368314)
Kolpakova ME, Zubarevsmall ACAA, Artamonova TD, Lisovskaya EK, Chefu SG, Yagmurov OD, Yaremenko AI, Vlasov TD (2017) Experimental model of osteonecrosis of the jaw in rats treated with zoledronic acid. Br J Oral Maxillofac Surg 55:156–159. https://doi.org/10.1016/j.bjoms.2016.10.006. (PMID: 10.1016/j.bjoms.2016.10.00627780611)
Silva PG, Ferreira Junior AE, Teofilo CR, Barbosa MC, Lima Junior RC, Sousa FB, Mota MR, Ribeiro Rde A, Alves AP (2015) Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis. Arch Oral Biol 60:1237–1245. https://doi.org/10.1016/j.archoralbio.2015.05.015. (PMID: 10.1016/j.archoralbio.2015.05.01526093347)
Barba-Recreo P, Pardo DC, de Vera JL, Garcia-Arranz M, Yebenes L, Burgueno M (2014) Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats. J Craniomaxillofac Surg 42:744–750. https://doi.org/10.1016/j.jcms.2013.11.005. (PMID: 10.1016/j.jcms.2013.11.00524342733)
(1960) The principles of humane experimental technique. Medical Journal of Australia 1:500–500 https://doi.org/10.5694/j.1326-5377.1960.tb73127.x.
Mardas N, Busetti J, de Figueiredo JA, Mezzomo LA, Scarparo RK, Donos N (2017) Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid. Clin Oral Implant Res 28:362–371. https://doi.org/10.1111/clr.12810. (PMID: 10.1111/clr.12810)
Mardas N, Dereka X, Stavropoulos A, Patel M, Donos N (2021) The role of strontium ranelate and guided bone regeneration in osteoporotic and healthy conditions. J Periodontal Res 56:330–338. https://doi.org/10.1111/jre.12825. (PMID: 10.1111/jre.1282533368312)
Duarte PM, Gonçalves P, Casati MZ, de Toledo S, Sallum EA, Nociti FH Jr (2006) Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats. J Periodontal Res 41:541–546. https://doi.org/10.1111/j.1600-0765.2006.00903.x. (PMID: 10.1111/j.1600-0765.2006.00903.x17076779)
Viera-Negrón YE, Ruan WH, Winger JN, Hou X, Sharawy MM, Borke JL (2008) Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol 34:76–82. https://doi.org/10.1563/1548-1336(2008)34[76:Eooaao]2.0.Co;2. (PMID: 10.1563/1548-1336(2008)34[76:Eooaao]2.0.Co;218478902)
Grant Information:: 14-007 Osteology Foundation
Contributed Indexing:: Keywords: Micro-CT analysis; Periodontal ligament; Preclinical study; Zoledronic acid
Substance Nomenclature:: 0 (Diphosphonates)
Entry Date(s):: Date Created: 20220422 Date Completed: 20231006 Latest Revision: 20231006
Update Code:: 20240104
DOI:: 10.1007/s00784-022-04503-z
PMID:: 35449246
: Czasopismo naukowe

Full Text Finder

Objectives: The objective of this study was to volumetrically assess changes in the periodontal microstructure under antiresorptive therapy.
Materials and Methods: Microtomographic scans from a total of 9 Dutch Belted rabbits having been randomly allocated to either the intravenous administration of amino-bisphosphonate (zoledronic acid) (Za) (n = 5) or a negative control group (nZa) (n = 4) were obtained at 10 months following a repeated drug administration. A quantification of the periodontal space thickness (P.Th) of both maxillary and mandibular most posterior premolars, as well as of the 2nd molars was performed. Bone micromorphometry was assessed by means of bone volume per total volume (BV/TV), the bone mineral density (BMD), trabecular thickness (Tb.Th), trabecular number (Tb.N), bone surface (BS), and the specific bone surface (BS/BV).
Results: Za was associated with significantly higher P.Th (P = 0.010), which was most pronounced in the upper jaw. Bone micromorphometry revealed no significant differences among the two groups, i.e., Za and nZa, for all the investigated parameters.
Conclusions: Volumetric analysis revealed that antiresorptive therapy was associated with periodontal space widening, whereas major effects on the bone micro-morphology could not be observed.
Clinical Relevance: A deep understanding of specific periodontal and alveolar bone alterations in patients under antiresorptive therapy might help to prevent the onset of medication-related osteonecrosis of the jaw.
(© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Informacja